News Releases

Orgenesis and Biosequel Enter Collaboration Agreement for Conducting Clinical Trials for Type 1 Diabetes Treatment in Russia
Nov 24, 2015

Lyfebulb and Orgenesis Form Strategic Collaboration with Focus on Delivering a Patient-Centered Practical Cure for Type 1 Diabetes
Nov 23, 2015

Orgenesis to Deliver Presentation and Poster Session at World Congress of Regenerative Medicine & Stem Cell in Shanghai, China
Nov 17, 2015

Orgenesis CEO to Participate in Diabetes Panel at BIO-Europe 2015
Oct 30, 2015

Orgenesis Included in Juvenile Diabetes Cure Alliance 2015 Update of Emerging Practical Cure Projects
Aug 31, 2015

Orgenesis Subsidiary MaSTherCell to Manufacture TxCell’s Lead Product Ovasave for Multi-National Phase 2b Trial
Jul 29, 2015

Orgenesis to Present at 3rd Global Life Sciences Conference in Warsaw
Jun 08, 2015

Orgenesis Founder Dr. Sarah Ferber to Present at American Diabetes Association's 75th Scientific Sessions
Jun 05, 2015

Orgenesis Wins Deal of the Month by Acquisition International Magazine
May 22, 2015

MaSTherCell And Curecell Sign Memorandum Of Understanding For Cell Therapy Partnership
May 22, 2015



RSS Feed

icon-rss Preview or subscribe to our news feed here.


Historical Press Releases

This website contains historical and archived press releases for Orgenesis Inc. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Orgenesis Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

Back to Top